Correlation Between Axim Biotechnologies and Cellectis
Can any of the company-specific risk be diversified away by investing in both Axim Biotechnologies and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axim Biotechnologies and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axim Biotechnologies and Cellectis SA, you can compare the effects of market volatilities on Axim Biotechnologies and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axim Biotechnologies with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axim Biotechnologies and Cellectis.
Diversification Opportunities for Axim Biotechnologies and Cellectis
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Axim and Cellectis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and Axim Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axim Biotechnologies are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of Axim Biotechnologies i.e., Axim Biotechnologies and Cellectis go up and down completely randomly.
Pair Corralation between Axim Biotechnologies and Cellectis
If you would invest 254.00 in Cellectis SA on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Cellectis SA or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axim Biotechnologies vs. Cellectis SA
Performance |
| Timeline |
| Axim Biotechnologies |
| Cellectis SA |
Axim Biotechnologies and Cellectis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axim Biotechnologies and Cellectis
The main advantage of trading using opposite Axim Biotechnologies and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axim Biotechnologies position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.| Axim Biotechnologies vs. Cellectis SA | Axim Biotechnologies vs. Biotron Limited | Axim Biotechnologies vs. Regenicin | Axim Biotechnologies vs. biOasis Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |